BMY
Bristol-Myers Squibb Co
Price:  
41.20 
USD
Volume:  
14,269,728.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy Relative Valuation

-105.6%
Upside

As of 2024-06-15, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is (2.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.20 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is -105.6%.

The range of the Relative Valuation is (72.67) - 86.75 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 24.0x - 30.9x 27.8x
Forward P/E multiples 19.9x - 24.2x 22.2x
Fair Price (72.67) - 86.75 (2.29)
Upside -276.4% - 110.6% -105.6%
41.20 USD
Stock Price
(2.29) USD
Fair Price

Bmy Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 -13.58
2024-06-13 -13.68
2024-06-12 -13.98
2024-06-11 -14.18
2024-06-10 -14.04
2024-06-07 -13.68
2024-06-06 -13.48
2024-06-05 -13.60
2024-06-04 -13.77
2024-06-03 -13.77
2024-05-31 -13.55
2024-05-30 -13.27
2024-05-29 -13.27
2024-05-28 -13.35
2024-05-24 -13.60
2024-05-23 -13.70
2024-05-22 -13.96
2024-05-21 -13.94
2024-05-20 -14.30
2024-05-17 -14.52
2024-05-16 -14.54
2024-05-15 -14.69
2024-05-14 -14.74
2024-05-13 -14.86
2024-05-10 -14.82
2024-05-09 -14.75
2024-05-08 -14.40
2024-05-07 -14.52
2024-05-06 -14.47
2024-05-03 -14.50
2024-05-02 -14.41
2024-05-01 -14.58
2024-04-30 -14.49
2024-04-29 -14.72
2024-04-26 -14.79
2024-04-25 -14.74
2024-04-24 -16.11
2024-04-23 -16.15
2024-04-22 -16.20
2024-04-19 -16.13
2024-04-18 -15.93
2024-04-17 -15.77
2024-04-16 -15.91
2024-04-15 -15.99
2024-04-12 -15.92
2024-04-11 -16.20
2024-04-10 -16.58
2024-04-09 -17.01
2024-04-08 -16.85
2024-04-05 -16.92